Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Windlas Biotech Ltd. ( (IN:WINDLAS) ) has issued an update.
Windlas Biotech Limited has announced the completion of the dispatch of its Annual Report and the Notice of the 24th Annual General Meeting for the financial year 2024-2025. This announcement, made in compliance with SEBI regulations, signifies the company’s adherence to regulatory requirements and its commitment to transparency with its stakeholders. The report and notice have been made available to shareholders, ensuring they are informed about the company’s financial performance and upcoming meeting details.
More about Windlas Biotech Ltd.
Windlas Biotech Limited operates in the pharmaceutical industry, focusing on manufacturing and marketing a range of pharmaceutical products. The company is known for its expertise in the development and production of generic drugs, catering to both domestic and international markets.
Average Trading Volume: 5,283
Current Market Cap: 18.93B INR
For an in-depth examination of WINDLAS stock, go to TipRanks’ Overview page.